Home » Topics » Medical technology

Medical technology
RSS

People in Places

Dec. 3, 2007

Product Briefs

Dec. 3, 2007

Del Global, Analogic form OEM imaging system supply pact

Dec. 3, 2007

Other News To Note

Dec. 3, 2007

Financings Roundup

Dec. 3, 2007

FDA Amendments Act - Detrimental To Advertising Prescription Drug

Dec. 3, 2007

New Discoveries May Aid HIV Prevention, Treatment

Dec. 3, 2007

By Anette Breindl

Panel: FDA's Science 'Weak'; Increased Funding Needed

Dec. 3, 2007

Fate Tempts VCs With Viable Stem Cell Business Model

Dec. 3, 2007

By Trista Morrison

Amid a flurry of stem cell news, Fate Therapeutics raised $12 million in a Series A financing to pursue in vivo and ex vivo modulation of adult stem cells. (BioWorld Today)

BioWorld Stock Report For Public Biotechnology Companies

Dec. 3, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...